Correction: Preclinical validation of Alpha-Enolase (ENO1) as a novel immunometabolic target in multiple myeloma

Arghya Ray1, Yan Song1, Ting Du1

  • 1Department of Medical Oncology, The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

Oncogene
|September 7, 2021
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos